Yes. Guselkumab has entered the medical insurance, and as of August 28, 2023, it has been included in the national medical reimbursement scope and can be reimbursed through the second level of social security. Guselkumab injection is a transparent, colorless to light yellow liquid. The main component is guselkumab, which is used to treat moderate to severe plaque psoriasis.